Rationale for anti-OX40 cancer immunotherapy
Aspeslagh, Sandrine, Postel-Vinay, Sophie, Rusakiewicz, Sylvie, Soria, Jean-Charles, Zitvogel, Laurence, Marabelle, Aurélien
Published in European journal of cancer (1990) (01.01.2016)
Published in European journal of cancer (1990) (01.01.2016)
Get full text
Journal Article
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
de Filette, Jeroen M K, Pen, Joeri J, Decoster, Lore, Vissers, Thomas, Bravenboer, Bert, Van der Auwera, Bart J, Gorus, Frans K, Roep, Bart O, Aspeslagh, Sandrine, Neyns, Bart, Velkeniers, Brigitte, Kharagjitsingh, Aan V
Published in European journal of endocrinology (01.09.2019)
Published in European journal of endocrinology (01.09.2019)
Get full text
Journal Article
Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation
Gauci, Marie-Léa, Lanoy, Emilie, Champiat, Stéphane, Caramella, Caroline, Ammari, Samy, Aspeslagh, Sandrine, Varga, Andrea, Baldini, Capucine, Bahleda, Rastilav, Gazzah, Anas, Michot, Jean-Marie, Postel-Vinay, Sophie, Angevin, Eric, Ribrag, Vincent, Hollebecque, Antoine, Soria, Jean-Charles, Robert, Caroline, Massard, Christophe, Marabelle, Aurélien
Published in Clinical cancer research (01.02.2019)
Published in Clinical cancer research (01.02.2019)
Get full text
Journal Article
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)
Bigot, Frédéric, Castanon, Eduardo, Baldini, Capucine, Hollebecque, Antoine, Carmona, Alberto, Postel-Vinay, Sophie, Angevin, Eric, Armand, Jean-Pierre, Ribrag, Vincent, Aspeslagh, Sandrine, Varga, Andrea, Bahleda, Rastislav, Menis, Jessica, Gazzah, Anas, Michot, Jean-Marie, Marabelle, Aurélien, Soria, Jean-Charles, Massard, Christophe
Published in European journal of cancer (1990) (01.10.2017)
Published in European journal of cancer (1990) (01.10.2017)
Get full text
Journal Article
Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?
Sol, Bastiaan, de Filette, Jeroen M K, Awada, Gil, Raeymaeckers, Steven, Aspeslagh, Sandrine, Andreescu, C E, Neyns, Bart, Velkeniers, Brigitte
Published in European journal of endocrinology (01.01.2021)
Published in European journal of endocrinology (01.01.2021)
Get full text
Journal Article
Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
De Meulenaere, Astrid, Vermassen, Tijl, Aspeslagh, Sandrine, Huvenne, Wouter, Van Dorpe, Jo, Ferdinande, Liesbeth, Rottey, Sylvie
Published in Oral oncology (01.07.2017)
Published in Oral oncology (01.07.2017)
Get full text
Journal Article
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
Tuyaerts, Sandra, Van Nuffel, An M T, Naert, Eline, Van Dam, Peter A, Vuylsteke, Peter, De Caluwé, Alex, Aspeslagh, Sandrine, Dirix, Piet, Lippens, Lien, De Jaeghere, Emiel, Amant, Frédéric, Vandecasteele, Katrien, Denys, Hannelore
Published in BMC cancer (28.05.2019)
Published in BMC cancer (28.05.2019)
Get full text
Journal Article
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?
Aspeslagh, Sandrine, Matias, Margarida, Palomar, Virginia, Dercle, Laurent, Lanoy, Emilie, Soria, Jean-Charles, Postel-Vinay, Sophie
Published in European journal of cancer (1990) (01.12.2017)
Published in European journal of cancer (1990) (01.12.2017)
Get full text
Journal Article
Importance of choice of materials and methods in PD‐L1 and TIL assessment in oropharyngeal squamous cell carcinoma
De Meulenaere, Astrid, Vermassen, Tijl, Creytens, David, Aspeslagh, Sandrine, Deron, Philippe, Duprez, Frederic, Rottey, Sylvie, Van Dorpe, Jo A, Ferdinande, Liesbeth
Published in Histopathology (01.09.2018)
Published in Histopathology (01.09.2018)
Get full text
Journal Article
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
Manson, Guillaume, Maria, Alexandre Thibault Jacques, Poizeau, Florence, Danlos, François-Xavier, Kostine, Marie, Brosseau, Solenn, Aspeslagh, Sandrine, Du Rusquec, Pauline, Roger, Maxime, Pallix-Guyot, Maud, Ruivard, Marc, Dousset, Léa, Grignou, Laurianne, Psimaras, Dimitri, Pluvy, Johan, Quéré, Gilles, Grados, Franck, Duval, Fanny, Bourdain, Frederic, Maigne, Gwenola, Perrin, Julie, Godbert, Benoit, Taifas, Beatris Irina, Forestier, Alexandra, Voisin, Anne-Laure, Martin-Romano, Patricia, Baldini, Capucine, Marabelle, Aurélien, Massard, Christophe, Honnorat, Jérôme, Lambotte, Olivier, Michot, Jean-Marie
Published in Journal for immunotherapy of cancer (03.12.2019)
Published in Journal for immunotherapy of cancer (03.12.2019)
Get full text
Journal Article
A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder
Wang, Xiaoxiao, Suppa, Mariano, Bruderer, Pascal, Sirtaine, Nicolas, Aspeslagh, Sandrine, Kerger, Joseph
Published in Case reports in oncology (15.06.2021)
Published in Case reports in oncology (15.06.2021)
Get full text
Journal Article
Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review
Wuyts, Stephanie C M, Cappelle, Charlotte A H, Verhaert, Marthe, Bravenboer, Bert, Aspeslagh, Sandrine
Published in Journal of oncology pharmacy practice (01.01.2024)
Published in Journal of oncology pharmacy practice (01.01.2024)
Get more information
Journal Article
Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms
de Filette, Jeroen M K, André, Stéphanie, De Mey, Lynn, Aspeslagh, Sandrine, Karmali, Rafik, Van der Auwera, Bart J, Bravenboer, Bert
Published in BMC endocrine disorders (22.11.2022)
Published in BMC endocrine disorders (22.11.2022)
Get full text
Journal Article
Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report
Simeni Njonnou, Sylvain Raoul, Aspeslagh, Sandrine, Ntsama Essomba, Marie-Josiane, Racu, Marie-Lucie, Kemta Lekpa, Fernando, Vandergheynst, Frédéric
Published in Journal of medical case reports (09.12.2022)
Published in Journal of medical case reports (09.12.2022)
Get full text
Journal Article
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection
Aspeslagh, Sandrine, Nemčovič, Marek, Pauwels, Nora, Venken, Koen, Wang, Jing, Calenbergh, Serge Van, Zajonc, Dirk M, Elewaut, Dirk
Published in The Journal of immunology (1950) (15.09.2013)
Published in The Journal of immunology (1950) (15.09.2013)
Get full text
Journal Article
Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection
Reilly, Emma C, Thompson, Elizabeth A, Aspeslagh, Sandrine, Wands, Jack R, Elewaut, Dirk, Brossay, Laurent
Published in PloS one (23.05.2012)
Published in PloS one (23.05.2012)
Get full text
Journal Article
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)
Postel-Vinay, Sophie, Lam, Vincent K, Ros, Willeke, Bauer, Todd M, Hansen, Aaron R, Cho, Daniel C, Stephen Hodi, F, Schellens, Jan H M, Litton, Jennifer K, Aspeslagh, Sandrine, Autio, Karen A, Opdam, Frans L, McKean, Meredith, Somaiah, Neeta, Champiat, Stephane, Altan, Mehmet, Spreafico, Anna, Rahma, Osama, Paul, Elaine M, Ahlers, Christoph M, Zhou, Helen, Struemper, Herbert, Gorman, Shelby A, Watmuff, Maura, Yablonski, Kaitlin M, Yanamandra, Niranjan, Chisamore, Michael J, Schmidt, Emmett V, Hoos, Axel, Marabelle, Aurelien, Weber, Jeffrey S, Heymach, John V
Published in Journal for immunotherapy of cancer (01.03.2023)
Published in Journal for immunotherapy of cancer (01.03.2023)
Get full text
Journal Article